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White frangipani (Plumeria alba L.) is tropical and subtropical plants, have been familiar used in many 
traditional medication as well as aromatherapy, especially for the flower part. Scientific study, but was 
not so many, reporting some pharmacological and toxicological effects of this plant which lead to more 
depth study at molecular level. This review describes the pharmacological and toxicological effect of 
the white frangipani and followed by its perspective on the future molecular medicine by identifying the 
protein target based on those biological effects. Hopefully this review could help scientist to get the 
summary from various study on white frangipani and raise the idea to study more about this plant at 
molecular level. 
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INTRODUCTION 
 
The family of Apocynaceae is widely distributed in tropic 
and subtropic regions, but it poorly plants up in the 
territory with a high temperature (El-kashef et al., 2015). 
The genera belongs to this family such as adenium, 
alstonia, alyxia, nerium, plumeria and vinca have been 
extensively reported having empirical evidence as folk 
medicines. However, due to the toxic milk latex of 
adenium, the plant was usually used for skin treatment 
such as to kill lice (Watt and Breyer-Brandwijk, 1933). 
Alstonia was traditionally used for respiratory disease 
(Shang et al., 2010), whereas alyxia was for post-natal 
care (Jamal et al., 2011). Nerium was empirically used for 
cancer treatment (Erdemoglu et al., 2003), and vinca was 
used in diabetic patient (Ghosh and Suryawanshi, 2001). 
Scientifically, those herbals have been reported having 
pharmacological effect such as antioxidant for adenium 
(Ebrahim  et  al.,  2013),  whereas  alstonia  is  an  herbal 
used for antivirus (Zhang et al., 2014). Alyxia is familiar to 
be used as antifungal (Rattanapan et al., 2012) while 
nerium and vinca are toxic herbals used for CNS 
depressant (Siddiqui et al., 1997) and antitumor (Cutts et 
al., 1960), respectively.  
To be more focused, plumeria is one of interesting 
plants from Apocynaceae to be explored in term of its 
diversity as well as the medicinal usage. This plant could 
grow up to 7 m in height (Sloan et al., 2007), branching 
with a milky latex inside the elongated green leaves, 
barks and stems (Murugan and Inamdar, 1987). Plumeria 
is a flowering plant commonly called as frangipani with a 
perfume fragrant (Wiart, 2006). The color of the flower 
could be white, yellow, dark red, and its hybrids in five 
numbers of corollas. In certain indigenous people like in 
Bali Island of Indonesia, this flower is used to perform 
worships  to   their   God   (Sujarwo   and    Keim,   2017).  
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Currently, the fragrant is having a high economic value to 
be used as an aromatherapy material (Verma, 2016).  
The latex of frangipani have been extensively studied 
containing alkaloid and sterol compounds which 
pharmacologically active as antitumor (Graham et al., 
2000), hypotensive and purgative (Gupta et al., 2016). 
The alkaloid such as  plumerianine have been studied as 
anti-anaphylactic (Vijayalakshmi et al., 2011) whereas an 
abundance of sterol compounds such as lupeol, taraxerol 
and betulin also have reported as anti-inflammatory 
(Geetha and Varalakshmi, 2001), anticancer (Tan et al., 
2011), and hypolipidemia (Tang et al., 2011). Among 
plumera species, Plumeria rubra (red flower) has been 
the most studied species in scientific herbal medicinal 
plants. Instead, Plumeria alba (white frangipani) is also 
interesting to be explored due to its abundance resource 
as well as red frangipani. 
Our previous study has found that the methanol extract 
of white frangipani leaves actively inhibit matrix 
metalloproteinase-9 (MMP9) with IC50 24.06 µg/ml 
(Anggoro, 2020). MMP9 is a zinc-dependent 
endopeptidase which involved in extracellular matrix 
(ECM) degradation. MMP9 was clinically indicated in a 
triple negative breast cancer, therefore has been 
potentially used as the protein target in cancer drug 
discovery (Putra et al., 2019). This finding prompts us to 
study more about the potential drug effect from this white 
frangipani. 
In this review, we will elaborate the pharmacological 
effect of white frangipani as antimicrobe, antioxidant, 
antiparasite, agent for metabolic and degenerative 
diseases, and dermatology. The toxicological effect of 
this species will be also furtherly reviewed including in 
vitro and in vivo studies. In the perspective, we will 
discuss about the protein which could be targeted in 
those mentioned biological activities at molecular level. 
This review is hopefully able to ease researcher to 
discover a potential lead compound in drug discovery and 
development based on natural product resource, 
especially from white frangipani.  
 
 
CHEMICAL CONSTITUENT OF WHITE FRANGIPANI 
 
White frangipani contains chemical substances such as 
amyrin, scopotein, iridoid isoplumericin, plumerein, 
plumeride cumarate and plumeride cumarate glycoside. 
The leaves and barks contain plumierin, resinic acid, 
fulvoplumierin, terpeneoid mixture, sterol, and plumeride. 
Furthermore, the bark also contains cytotoxic iridoid, 
allamcin, allamandin, 2,5-dimethoxy-p-benzoquinone, 
plumericin and liriodindrin. The roots of white frangipani 
also contains iridoid, tannin and alkaloid (Shinde et al., 
2014). The essential oil from the flower are composed of 
geraniol, citronellol, phenyl ethylalcohol and some linalool 
(Gupta et al., 2016). 
The     database     of     natural    product   compounds, 
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http://bidd2.nus.edu.sg/NPASS/organism.php?org_id=NP
O2827 list downs a number of chemical substance in 
white frangipani, that is, (+/-)-1,4-O-diferuloyl-
secoisolariciresionol, betulin, lupeol, asam betunolat, 
(8Ar)- 8A-hydroxy-3,3,6,6,8,8-hexamethyl-1,2-
benzodioxine-5,7-dione, betulin, vitamin E, beta-amirin, 
friedeline, taraxerol, and 3-O-acetylbetulin.  
Figure 1 represents five natural compounds deposited 
in white frangipani. The sterol compounds of taraxerol, 
lupeol and betuline and also the coumarone in 
fulvoplumericin seem like having structure similar to the 
cholesterol esterase inhibitor. Moreover, the geraniol is 
rich of double bonds with OH terminal, suitable for 
antioxidant against 2-hydroxybiphenyl-3-monooxygenase. 
These are only a few structures in white frangipani that 
could be proposed for molecular medicine in the 
treatment of hyperlipidemia, cardiovascular etc. Figure 1 
illustrate the structure of five chemical substances being 
identified in white frangipani. 
 
 
PHARMACOLOGICAL ACTIVITY 
 
Antimicrobial 
 
The flower of white frangipani has been reported having 
antibacterial activities against Escherichia coli, Proteus 
vulgaris, Staphylococcus aureus, Klebsiella pneumoniae, 
Pseudomonas aeruginosa, Staphylococcus 
saprophyticus, Enterococcus faecalis and Serratia 
marcescens by using disc diffusion method (Syakira and 
Brenda, 2010). The methanolic-water (4:1) extract from 
this flower demonstrated the highest reading up to 13.33 
mm inhibition zone towards E. coli at 80% concentration 
which is equivalent to the positive control, streptomycin. 
In the testing to S. saprophyticus, the 80% extract 
showed 10.33 mm of the zone which is lower than the 
positive control (19.67 mm). In P. vulgaris, the extract 
performed 12.33 mm of the zone which is also below the 
positive control (15 mm). The extract was then applied to 
S. marcescens demonstrating 11 mm of the zone which 
is lower than the control (17.33 mm). Although 
approximately the antibacterial activity of the extract is 
still below than the positive control, there are still potential 
activity of the extract as antibacterial agent, especially to 
E. coli. However, all extracts are still less potent than 
gentamycin as the second positive control. To all bacteria 
species, gentamycin showed above 20 mm of inhibition 
zone, whereas the 80% extract showed less than 15 mm 
of inhibition. White frangipani has been studied its 
biological activity against Propionibacterium acnes in the 
effort to formulate its leaves ethanolic extract into water 
leached-based ointment (Ningsih et al., 2017). The 
antiacne properties of white frangipani was indicated by 
24 mm zone of inhibition on P. acne growth at 5 ppm of 
the extract in the ointment concentration. The alkaloid 
and  saponin  being contained in the leaves was believed 
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Figure 1. The structures of five chemical constituents identified in white frangipani. 
Source: Shinde et al. (2014) and Gupta et al. (2016). 
 
 
 
to be responsible for the antiacne activity.  
Streptococcus pyogene is a bacteria to cause 
pharingitis and tonsillitis. Jiwantono et al. (2017) reported 
that the ethanolic extract of white frangipani flower 
disrupted the colony growth of this bacteria down to 7.81 
mg/ml based on the minimum bactericidal concentration 
using dilution method (Jiwantono et al., 2017). 
Unfortunately, the minimum inhibition concentration could 
not be observed due to the inconsistency of the level of 
turbidance for each treated colony. 
Instead of antibacterial effect from white frangipani has 
been well documented, its antifungal effect was also 
reported. The ethanolic extract of white frangipani flower 
was proposed to be a dental cleanser by evaluating it 
against C. albicans colony growth (Wadianur et al., 
2018). The extract at the highest concentration 100% 
was observed to inhibit the fungus with the reduction of 
the concentration down to 3.080 × 10
8
 CFU/ml from its 
starting concentration at 6.439 × 10
8 
CFU/ml (negative 
control). 
 
 
Antioxidant 
 
There have been well studied, that reactive oxygen stress 
(ROS) causing oxidized state associating with many 
pathologic condition such as cancer, inflammation, 
cardiovascular diseases etc. White frangipani has been 
reported to have antioxidant activity by extracting its 
flower  using   ethanol  and  acetic  acid  (Wrasiati  et  al., 
2011). The ethanolic extract performed 18.19% 
antioxidant capacity against DPPH, whereas the acetic 
acid extract demonstrated 12.74% of its capacity as well. 
Although it is not that high capacity, the antioxidant 
activity of white frangipani flower could be contributed by 
its vitamin C substance as determined using 2,4-
dinitrophenylhydrazine method. The vitamin C content in 
the flower is calculated as 3.08 and 3.13% for the 
ethanolic extract and acetic acid extract, respectively. 
Dawood et al. (2016) reported the antioxidant activities 
of white frangipani leaves using various methods that is, 
FRAP, DPPH free radical scavenging and reducing 
power assay. The samples were prepared on methanolic 
extract and its crude polysaccharide. The antioxidant 
activities were observed for polysaccharide at a 
concentration 3 mg/ml showing a FRAP value of 0.0915 
and 0.0901 μmol Fe (II)/g for methanolic extract and 
PAPs, respectively. Using DPPH method at the 
concentration of 3 mg/ml, the percentage inhibition was 
94.28 and 84.18 for the methanolic extract and Plumeria 
alba polysacharrides (PAPs), respectively. However, the 
reducing power of the methanolic extract was higher than 
that of PAPs at a concentration 3 mg/ml. 
 
 
Antiparasite 
 
White frangipani stem bark has been used in traditional 
medication in Ghana as antimalarial. An alternative way 
around to find  antimalarial  agent  instead  of  Artemisinin  
 
 
 
 
has been used for so long time, prompting the utilization 
of this plant to overcome malarial case. Scientific studies 
then reported that the aqueous extract (30-300 mg/kg) as 
well as dichloromethane/methanol (30-300 mg/kg) of this 
part of the plant showed significant effect towards mice 
infected by Plasmodium berghei (Boampong et al., 2013). 
Surprisingly, this is equivalent to the effect of artemether 
and lumefantrine, curatively, and sulfadoxine/ 
pyrimethamine, prophylactically. However, the 
dichloromethane/methanol extract reduced the 
parasitemia curatively, (p≤ 0.05-0.01), but it was not 
prophylactically. 
As mentioned before, that the fragrant smell of white 
frangipani has been used as aromatherapy. This fragrant 
comes from the content of essential oil having high value 
in beautification business. One study reported the 
utilization of this flower by distilling the essential oil using 
water distillation and it is applied for anti-repellant 
(Nurcahyo and Purgiyanti, 2017). The collected oil was 
then formulated in to gel bases with a concentration 5 to 
10% demonstrating the preference of respondent to use 
formula 2 as the anti-repellant. This formula consists of 
menthol 7.5%, camphor 4%, olive virgin oil 20%, and 
essential oil of white frangipani 10%.  
 
 
Agent for metabolic and degenerative diseases 
 
Rheumatic arthritis is a chronic symptom of inflammatory 
diseases leading to cartilage destruction as well as its 
bone erosion. Although there have been drugs available 
for this symptoms such as NSAID and SAID, however, 
the adverse drug reaction such as gastrointestinal 
disorder making these drugs should be minimized in 
therapy. Study in 2014 reported the potency of white 
frangipani being used as antiarthritis (Choudhary et al., 
2014). In this study, hydroalcoholic extracts (30:70) from 
white frangipani leaves was further fractionated into 
ethylacetate and n-buthanol extracts. These two extracts 
were administered orally to Sprague-Dawley arthritic rats 
induced by formaldehyde and Freund’s complete 
adjuvant. From the physical assessment and the 
histopathology test, the 100 and 200 mg/kg doses of 
ethylacetate extract and n-buthanol extract caused a 
significant (p≤0.05-0.01) reduction in paw swelling in both 
models. Erythrocyte sedimentation rate (ESR) and spleen 
weight decreased significantly (p < 0.01) in arthritic rats 
treated with extracts. Then, there was a significant 
improvement (p < 0.05) in thymus weight in ethylacetate 
extract treated rats whereas another significant 
improvement (p < 0.01) was also seen in hemoglobin 
level (Hb) in diclofenac treated group. Motor 
incoordination and nociceptive threshold were also 
significantly improved (p≤0.05-0.01). 
Hyperlipidemia is one of the risk factors in 
cardiovascular diseases. The usage of synthetic 
hypolipidemic agent has been  successfully  lowering  the  
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lipid blood level. However, alongside with this, the toxicity 
of synthetic hypolipidemic agent such orlistat have been 
prompting the use of herbal medicine to overcome such 
metabolic disorder. Study by Rahman et al. (2014) 
reported the potential effect of white frangipani flower as 
hypolipidemic agent. Anti-cholesterol assay of the 
extracts was demonstrated by white frangipani extract 
with 52% of activity. This result shows the potency of 
white frangipani flower as the hypolipidemia although the 
activity is still not greater than simvastatin (92%) as the 
positive control. Diabetes is also metabolic disorder 
detected by hyperglycemia after post prandial status due 
to the insulin lack or resistance. This disease leads to 
many complications such cardiovascular and micro 
vascular disease. White frangipani was reported having 
hypoglycemic activities as evaluated by oral glucose 
tolerance test on mice (Kadébé et al., 2016).  
 
 
TOXICOLOGICAL ACTIVITY 
 
Along with the pharmacological activities of white 
frangipani have been well reported, the toxicological 
properties should be aware accordingly. It is well known 
that that more potent compounds being drug, the more 
potential to be toxic. For example, digitalis leaves are 
used to treat heart failure, but it is toxic. The acute and 
sub-acute toxicities of white frangipani was conducted in 
Sprague-Dawley rats (Tessou et al., 2013). The 
hydroalcoholic extract of the roots was administered 
orally as a single dose of 5 g/kg for acute toxicity, 
whereas the dose was divided into three administrations 
that is, 250, 500 and 100 mg/kg for 28 days. Some 
parameters were then examined including the body 
weight and blood glucose which were continuously 
monitored every week. Other parameters such as 
hematological, biochemical, and a relative organ weight 
were also determined at the end of the 28 days 
administration. It was observed, that there was no acute 
toxicity in the mentioned dose. Further sub-acute toxicity 
test also demonstrated no dead was induced by the 
extract, up to 1000 mg/kg. In accordance, the tissue 
organ histologic parameter also did not show any 
changing during the white frangipani extract exposure, 
supporting that this extract did not have both acute and 
sub-acute toxicities.  
In the cytotoxicity study, the flower of white frangipani 
has been evaluated against colorectal cancer cell model, 
that is, colo 205 as reviewed (Hanan et al., 2018). The 
sample was prepared in silver nanoparticle with a 
concentration 4.5 and 5.5 µg/ml exposed for 48 and 24 h, 
respectively. Both concentrations demonstrated 
cytotoxicity by apoptotic mechanism with the time/dose-
dependent parameter (Mata et al., 2015). This result 
proposed that white frangipani flower was potential for 
anticancer especially for colorectal cancer. The white 
frangipani   leaves     extracted    using   dichloromethane  
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(DCM) and tested its toxicity using brime shirmp lethality 
test (BSLT) (Hidajati and Qodriyah, 2018). BSLT is a 
simple method for cytotoxicity based on the killing ability 
of the test compounds on a simple zoological organism-
brine shrimp (Artemia salina) (Harwig and Scott, 1971; 
Wu, 2014). The DCM extract was further extracted using 
hexane-ethylacetate showing LC50 54.448 µg/ml being 
suggested for further study for its potential as cancer 
cytotoxic agent. 
 
 
PERSPECTIVES ON BIOLOGICAL ACTIVITY AT 
MOLECULAR LEVEL 
 
In a decade, white frangipani has been studied for its 
potential effect as antimicrobial, antioxidant, antiparasite 
and agent for metabolic and degenerative diseases along 
with its toxicities either in vitro or in vivo experiment. 
Although those studies have been good for further 
development, however, the type of testing is limited for in 
vitro cellular as well as in vivo animal level. There is 
almost no study at molecular level for this plant. 
It is well known that the study at molecular level is 
important to find the more selective pathway (Holmes, 
1998). The less selective target is postulated as the more 
risk the drug to be toxic or having adverse side effect 
(Buckley and Sanders, 2000). Molecular level includes 
enzyme, receptor, signal transduction and nucleic acid as 
the drug target. Those drug targets interact with the drug 
through chemical interactions such as electrostatic, 
hydrogen and hydrophobic bondings. In this perspective, 
we will focus on enzyme and receptor, whereas for signal 
transduction and nucleic acid, it would be discussed in 
another review. For enzyme and receptor, the drug is 
commonly binding to the active site of the protein 
surrounded by important amino acid residues. The drug-
protein binding stability is depending on their free energy 
of binding and drug’s structural conformation (Patrick, 
2013). 
To date, science and technology in protein (proteomic) 
has been greatly developed to facilitate studies on drug-
protein binding at the molecular level (Lomenick et al., 
2011). The gene of protein (enzyme and receptor) could 
be isolated from the cell of protein being deposited and 
then expressed into microorganism such as E. coli and 
observed as a protein recombinant (Gasser et al., 2008). 
This protein recombinant could be further studied either 
in silico or in vitro experiment. This part will tabulate the 
proteins being involved in the biological effect of white 
frangipani as reviewed above. These proteins have been 
crystallized and deposited in protein data bank 
(www.rcsb.org). 
As presented in Table 1, the protein targets for 
antimicrobe are represented by aminopeptidase A, 
nicotinic acid mononucleotide adenylyltransferase, beta-
ketoacyl-acyl-carrier transferase and dihydropteroate 
synthetase. Aminopeptidase A is an  exopeptidase  which  
 
 
 
 
hydrolyzes the N-terminal glutamic acid or aspartic acid. 
One of the inhibitors of this enzyme is amastatin, a 
natural peptide isolated from Streptomyces sp (Hiranuma 
et al., 1997). Nicotinic acid mononucleotide 
adenylyltransferase is an enzyme which indispensably 
catalyzing in the biosynthesis of NAD
+
 and NADP
+
. A 
study reported that this enzyme was inhibited by 
compound bearing – hydrazine and tricyclic scaffold 
(Sorci et al., 2009). Beta-ketoacyl-acyl-carrier transferase 
is the enzyme that involved in fatty acid biosynthesis 
system dissociation. This biosynthesis occurs in bacteria 
that could be inhibited by compounds with scaffold 
benzylidene-hydrazide (Lee et al., 2012). Dihydropteroate 
synthetase is an enzyme in bacteria which catalyzes the 
reaction between (2-amino-4-hydroxy-7,8-dihydropteridin-
6-yl)methyl diphosphate + 4-aminobenzoate (PABA). The 
product, i.e. dihydropteroate and diphosphate were 
inhibited by sulfonamide drug. However, the 
dihydropteroate synthetase has been resistant toward 
this sulfonamide (Wang et al., 1997). 
In antioxidant, the protein targets are represented by 
glutathione reductase, human peroxidase (peroxidoxin) 
and 2-hydroxybiphenyl-3-monooxygenase. Glutathione 
reductase catalyzes the conversion of glutathione 
disulfide into glutathione which depends on the NADPH 
coenzyme. This reaction is important in maintaining the 
blood glucose level activated by flavin related compounds 
(Beutler, 1969). Human peroxidase or peroxidoxin 
regulates the intracellular concentration of H2O2 by 
reducing it into a more proper electron donating agent. 
This enzyme is activated by hydroquinone compound 
leading to the formation of DNA-adducts to the cell 
(György et al., 1993). 2-hydroxybiphenyl-3-
monooxygenase is an oxidoreductase catalyzing the 
reaction between 2-hydroxyphenyl and NADH to form the 
products that is, 2,3-hydroxybiphenyl and NAD
+
. The 
substrate of this enzyme is 2-hydroxybiphenyl, therefore, 
the inhibitor could be designed based on the similar 
structure with the substrate (Kanteev et al., 2015). 
The protein targets of antiparasite are represented by 
lactate dehydrogenase, enoyl-acyl-carrier-protein 
reductase, actin II and pyridoxal-5-phosphate synthase. 
Lactate dehydrogenase (LDH) oxidizes lactic acid into 
pyruvic acid which is crucial for parasite life such as P. 
berghei. Gossypol, a natural compound from cotton 
seeds inhibits this enzyme with Ki 1.4 µM towards LDH-
B4 (Yu et al., 2001). Enoyl-acyl-carrier-protein reductase 
is an important enzyme to synthesize fatty acid in 
parasite through acetyl-malonyl-butyril conversion. 
Pyridinone compounds have been reported having 
inhibition to this enzyme (Heath and Rock, 1995). Actin II 
is a protein which highly conserved in a various cell 
motility and expressed in all eukaryotic cells and 
contributes on parasite gliding motility. This protein could 
be inhibited by chondroamide, an analog by binding into 
the actin filament and blocking the growth of the parasite 
on the cell layer (Ma et al.,  2013). Pyridoxal-5-phosphate  
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Table 1. The protein, resourced cell, type of protein and PDB code could be targeting by white frangipani according to the biological activity at molecular level. 
 
Biological activity Protein target Resourced cells Type of protein PDB code 
Antimicrobial 
Aminopeptidase A E. coli Enzyme 1GYT (Strater et al., 1999) 
Nicotinic acid mononucleotide Adenylyltransferase S. aureus Enzyme 2H29 (Han et al., 2006)
 
Beta-ketoacyl-acyl-carrier transferase M. tuberculosis Enzyme 1HZP (Scarsdale et al., 2001) 
Dihydropteorote synthetase Streptococcus pneumoniae Enzyme 2VEF (Levy et al., 2008) 
     
Antioxidant 
Glutathione reductase Homo sapiens Enzyme 1K4Q (Savvides et al., 2002) 
Human peroxidase Homo sapiens Enzyme 1PRX (Choi et al., 1998) 
Peroxidoxin Plasmidium falcifarum Enzyme 4D73 (Staudacher et al., 2015) 
2-hydroxybiphenyl-3-monooxygenase Pseudomonas nitroreducens Enzyme 6EM0 (Bregman-Cohen et al., 2018) 
     
Antiparasite 
Lactate dehydrogenase Plasmodium berghei Enzyme 1OC4 (Winter et al., 2003) 
Enoyl-acyl-carrier-protein reductase Plasmodium berghei Enzyme 3F4B (Yu et al., 2008) 
Actin II Plasmodium berghei Receptor 4CBX (Vahokoski et al., 2014) 
Pyridoxal-5-phosphate synthase Plasmodium berghei Enzyme 4ADS (Guédez et al., 2012) 
     
Arthritis 
T cell receptor beta chains Homo sapiens Receptor 2AXH (Li et al., 2005) 
PI3K gamma Homo sapiens Enzyme 2A4Z (Camps et al., 2005) 
Immune receptor Homo sapiens Receptor 4MCY (Scally et al., 2013) 
BTK mutant (F435T,K596R) Homo sapiens Enzyme 3T9T (Kim et al., 2011) 
     
Hyperlipidemia 
M37 lipase Photobacterium sp. M37 Enzyme 2ORY (Jung et al., 2008) 
Gastric lipase  Homo sapiens Enzyme 1HLG (Roussel et al., 1999) 
Cholesterol esterase Bos taurus Enzyme 2BCE (Chen et al., 1998) 
Cholesterol oxidase Streptomyces sp. (strain SA-COO) Enzyme 4U2S (Golden et al., 2014) 
     
Diabetes 
Alpha-glucosidase Geobacillus sp. HTA-462 Enzyme 2ZE0 (Shirai et al., 2008) 
PPAR gamma Homo sapiens Receptor 3ET0 (Artis et al., 2009) 
Murine 11b-hydroxysteroid dehydrogenase Mus musculus Enzyme 1Y5M (Zhang et al., 2005) 
Glucokinase Homo sapiens Enzyme 3IMX (Bebernitz et al., 2009) 
 
 
 
synthase catalyzes the condensation of serine 
and homocysteine to form cystathionine. This 
enzyme is de novo synthesized by parasite as a 
crucial cofactor during erythrocytic schizogony. 
Compounds bearing  pyridoxyl-tryptophan  methyl 
esters have been reported to disrupt this enzyme 
biomolecular mechanism (Müller et al., 2009). 
Figure 2 illustrates the 3D structure of three 
proteins those are targeted for antimicrobial, 
antioxidant and antiparasite. 
Many proteins are involved in the molecular 
mechanism of rheumatoid arthritis but four of 
them are T cell receptor beta chains, PI3K 
gamma, immune receptor, BTK mutant (F435T, 
K596R). T cell  receptor  beta chains is commonly 
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Figure 2. The 3D structure of aminopeptidase A (1GYT), glutathione reductase (1K4Q) and lactate dehydrogenase 
(1OC4) as visualized using Discovery Studio (www.accelrys.com) in surface models. 
 
 
 
found in the surface of T cell in lymphocyte. This protein 
has a function to recognize the peptide antigen bound to 
major histocompatibility complex. A MHC peptide has 
been studied as the T cell receptor beta chains 
antagonist, so that can reduce the antigen-receptor 
binding leading to arthritic healing activity (Lyons et al., 
1996). PI3K gamma is encoded by PI3CG gene, so that 
the protein is belonged to pi3/pi4-kinase family, having a 
function to phosphorylate phosphoinositides on the 3-
hydroxyl group of the inositol ring.  The phosphorilated 
product is important to modulate extracellular signal 
including inflammatory agent leading to rheumatoid 
arthritis. Compounds having structure thiazolidinones and 
2-aminoheterocycles were two of reported agents to 
inhibit this such protein (Venable et al., 2010). Immune 
receptor is a membrane receptor having native ligand 
such as cytokine to proceed immunological response. 
Some antidepressants such as imipramine, 
clomipramine, and citalopram have been studied having 
antagonistic action against cytokine receptor (Vellucci, 
2010). BTK mutant (F435T, K596R) is also a kinase 
enzyme playing a crucial role in oncogenic and 
proinflammatory signaling. This protein is blocked by 
imidazole compounds, as reported (Kim et al., 2011). 
In hyperlipidemia, M37 lipase, gastric lipase, 
cholesterol esterase and cholesterol oxidase could be 
targeted as the protein which are responsible to this 
metabolic disorder. Lipase is an enzyme having a 
function to hydrolyze the triglyceride fatty acid forming 
triacylglycerol and free fatty acid. Fenfluramine and 
sibutramine are drugs for the treatment of obesity having 
lipolysis mechanism by inhibiting lipase enzyme (Heck et 
al., 2000). However, these two drugs have been 
withdrawn from the market in 1997 and 2010, 
respectively due to the serious adverse side effect on 
cardiovascular system (Kang and Park, 2012). 
Cholesterol esterase is an enzyme which catalyzes the 
hydrolysis of cholesterol ester to be free cholesterol and 
free fatty acid. The free cholesterol will be converted into 
many types like chylomicron, remnant, HDL, LDL and 
VLDL that could lead the hypercholesterolemia if the 
metabolisms  were   not   well   maintained.   Compounds 
bearing p-nitrophenyl, isocoumarine and cholesteryl-N-
alkyl carbamate have been reported to inhibit this 
enzyme (Hosie et al., 1987; Heynekamp et al., 2008). 
Cholesterol oxidase is another enzyme working on 
cholesterol metabolism by oxidizing the hydroxyl group of 
cholesterol into ketone. This enzyme is inhibited by some 
surfactants such as hydroxypolyethoxy dodecane, twen-
20 and triton-X45 (Miner-Williams, 1980).  
Four proteins including alpha-glucosidase, Peroxisome 
proliferated –activated receptor (PPAR) gamma, murine 
11beta-hydroxysteroid dehydrogenase, and human 
glucokinase have been targeted in diabetic therapy. 
Alpha-glucosidase increases the blood glucose level by 
catalyzing the hydrolysis of a complex carbohydrate into 
glucose. This enzyme is inhibited by acarbose while the 
real mechanism of action is still remained unclear (Van 
de Laar et al., 2005). PPAR gamma receptor has a 
function as the regulator of lipid uptake and 
adipogenesis. A combined structure of coumarine and 
chalcone have been reported in activation of this receptor 
(agonist) to make the insulin receptor to be sensitized 
(Kim et al., 2019). Murine 11beta-hydroxysteroid 
dehydrogenase is a reductase having a microsomal short 
chain to catalyze glucocorticoid which is biologically 
active (cortisol) into inactive glucocorticoid (cortisone and 
11-dehydrocortisone). In diabetes, an excess of cortisol 
could cause insulin intolerance and delay the wound 
healing, one of the complicated risk of diabetes mellitus. 
A small non-steroidal molecule called as BVT.2733 has 
been studied as the inhibitor of murine 11beta-
hydroxysteroid dehydrogenase to low the hepatic 
PEPCK, glucose-6-phosphate mRNA, blood glucose and 
serum insulin concentration (Alberts et al., 2002). Human 
glucokinase converts glucose to glucose-6-phosphate 
through phosphorylation leads to glycogen synthesis. 
This enzyme is sensitive to oxidative stress of cells, 
especially to beta cells. Piragliatin, a small molecule 
bearing structure incorporating pyrimidine linked to 
chlorobenzene sulfone by amide chain with methyl 
cyclopentanone as the side chain being attached to the 
linker (Matschinsky and Porte Jr, 2010). Figure 3 
illustrates the  3D  structure  of  three  proteins  those  are  
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Figure 3. The 3D structure of T cell receptor beta chains (2AXH), M37 lipase (2ORY) and alpha-glucosidase (2ZE0) 
as visualized using Discovery Studio (www.accelrys.com) in surface models. 
 
 
 
targeted for rheumatoid arthritis, hyperlipidemia and 
diabetes. 
 
 
CONCLUSION 
 
This review has elaborated the molecular target that 
could be proposed for the molecular medicine of white 
frangipani (Plumeria alba L.). The availability of the 
crystal structure of the protein target facilitates the drug 
design from the identified chemical substance from this 
plant to be molecularly interacted with the binding site of 
the protein by in silico. This will lead the novel molecular 
medicine from white frangipani by speeding up the time 
of investigation. The future molecular medicine could be 
more efficient since the resource of this plant is quite 
abundant especially in tropical as well as subtropical 
areas.  
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